Humoral immunity against diphtheria, tetanus and poliomyelitis after antineoplastic therapy in children and adolescents - A retrospective analysis

Vaccine

Volumn 18, Issue 26, 2000, Pages 2999-3004

  von der Hardt, K ^a   Jungert J ^a   Beck, J D ^a   Heininger, U ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Antineoplastic therapy; Children; Diphtheria; Humoral immunity; Poliomyelitis; Tetanus

Indexed keywords

DIPHTHERIA ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; TETANUS ANTIBODY; TETANUS TOXIN; TETANUS TOXOID; TOXIN ANTIBODY; VIRUS ANTIBODY;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHEMOTHERAPY; CHILD; CLINICAL TRIAL; DIPHTHERIA; FEMALE; HISTIOCYTOSIS; HODGKIN DISEASE; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROTYPE; SOLID TUMOR; TETANUS;

ADOLESCENT; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DIPHTHERIA TOXIN; HUMANS; IMMUNIZATION; MALE; POLIOVIRUS; RETROSPECTIVE STUDIES; TETANUS TOXIN;

EID: 0342657081     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00092-X     Document Type: Article

References (25)

1. Kaletsch U., Kaatsch P., Michaelis J. Jahresbericht 1995 des Deutschen Kinderkrebsregisters. 1996;Mainz.
2. Alanko S., Pelliniemi T.T., Salmi T.T. Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia. Cancer. 69:1992;1481-1486.
3. Alanko S., Salmi T.T., Pelliniemi T.T. Recovery of blood T-cell subsets after chemotherapy for childhood acute lymphoblastic leukemia. Pediatr. Hematol. Oncol. 11:1994;281-292.
4. Mustafa M.M., Buchanan G.R., Winick N.J., McCracken G.H., Tkaczewski I., Lipscomb M., Ansari Q., Agopian M.S. Immune recovery in children with malignancy after cessation of chemotherapy. J. Pediatr. Hematol. Oncol. 20:1998;451-457.
5. Sutter R.W., Pallansch M.A., Sawyer L.A., Cochi S.L., Hadler S.C. Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccination. Ann NY Acad. Sci. 754:1995;289-299.
6. Siber G.R. Methods for estimating serological correlates of protection. Dev. Biol. Stand. 89:1997;283-296.
7. Enke B.U., Bökenkamp A., Offner G., Bartmann P., Brodehl J. Response to diphtheria and tetanus booster vaccination in pediatric renal transplant recipients. Transplantation. 64:1997;237-241.
8. Stiffler-Rosenberg G., Fey H. Messung von Tetanus-Antitoxin mit dem Enzyme-linked immunosorbent assay (ELISA). Schweiz. Med. Wochenschr. 107:1977;1101-1104.
9. Maass G., Weber B., Doerr H.W. Untersuchungen zur Immunitätslage gegen Poliomyelitis. Dtsch. Med. Wochenschr. 116:(39):1991;1457-1462.
10. van der Does-van den Berg A., Hermans J., Nagel J., van Steenis G. Immunity to diphtheria, pertussis, tetanus and poliomyelitis in children with acute lymphocytic leukemia after cessation of chemotherapy. Pediatrics. 67:1981;222-229.
11. Dupuy J.M., Kourilsky F.M., Fradelizzi D., Feingold N., Jacquillat C.L., Bernard J., Dausset J. Depression of immunologic reactivity of patients with acute leukemia. Cancer. 27:1971;323-331.
12. Hitzig W.H., Plüss H.J., Joller P., Pilgrim U., Tacier-Eugster H. Studies on the immune status of children with acute lymphocytic leukemia. Clin. Exp. Immunol. 26:1976;403-413.
13. Kung F.H., Orgel H.A., Wallace W.W., Hamburger R.N. Antibody production following immunization with diphtheria and tetanus toxoids in children receiving chemotherapy during remission of malignant disease. Pediatrics. 74:1984;86-89.
14. Ridgway D., Wolff L.J., Deforest A. Immunization response varies with intensity of acute lymphoblastic leukemia therapy. AJDC. 145:1991;887-891.
15. Ridgway D., Wolff L.J. Active immunization of children with leukemia and other malignancies. Leuk. Lymphoma. 9:1993;177-192.
16. Smith S., Schiffman G., Karayalcin G., Bonagura V. Immunodeficiency in long-term survivors of acute lymphoblastic leukemia treated with Berlin-Frankfurt-Munster therapy. J. Pediatr. 127:1995;68-75.
17. Diedrich S., Schreier E. Immunitätslage gegen Poliomyelitis. Polio-Serosurveillance 1993. Dtsch. Med. Wochenschr. 120:1995;239-244.
18. Haas R., Petersen E.E., Neumann-Haefelin D., Doerr H.W., Eggert E., Enders G., Firtzlaff R., Kuwert E., Lennartz H., Schmidt W.A.K. Untersuchungen über die Immunitätslage gegen Poliomyelitis. Dtsch. Med. Wochenschr. 100:1975;3-8.
19. Maass G. Schutzimpfungen gegen Poliomyelitis. Spiess H. Schutzimpfungen. 1985;Medizinische Verlagsgesellschaft, Marburg.
20. Peebles T.C., Levine L., Eldred M.C., Edsall G. Tetanus toxoid emergency boosters. N. Engl. J. Med. 280:1969;575-581.
21. Pilars de Pilar C.E., Spiess H. Diphtherie- und Tetanusantikörper bei Kindern und jungen Erwachsenen. Dtsch. Med. Wochenschr. 106:1981;1341-1345.
22. Rieger J., Kuhlmann D. Diphtherieimmunität der Bevölkerung in Deutschland. Gesundheitswesen. 56:1994;667-671.
23. Melnick J.L. Live attenuated poliovirus vaccines. Plotkin S.A., Mortimer E.A. Vaccines. 1994;Saunders, Philadelphia.
24. Wassilak S.G.F., Orenstein W.A., Sutter R.W. Tetanus toxoid. Plotkin S.A., Mortimer E.A. Vaccines. 1994;Saunders, Philadelphia.
25. de Vaan G.A., van Munster P.J., Bakkeren J.A. Recovery of immune function after cessation of maintenance therapy in acute lymphoblastic leukemia (ALL) of childhood. Eur. J. Pediatr. 139:1982;113-117.